SEM
Select Medical Holdings Corporation
NYSE · Healthcare · Medical - Care Facilities · US
$16.51
−0.09%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 5.5B | 5.5B | 5.2B | 6.7B | 6.3B |
| Cost of Revenue | 4.9B | 4.8B | 4.6B | 5.7B | 5.6B |
| Gross Profit | 588.0M | 629.3M | 633.6M | 932.0M | 733.4M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 160.8M | 154.4M | 225.9M | 170.2M | 153.0M |
| General & Admin Expense | 160.8M | 154.4M | 225.9M | 170.2M | 153.0M |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 105.4M | 140.3M | 139.5M | 207.0M | 177.1M |
| Total Operating Expenses | 266.2M | 294.7M | 365.3M | 377.2M | 330.1M |
| Cost and Expenses | 5.2B | 5.1B | 4.9B | 6.1B | 5.9B |
| Operating Income (EBIT) | 321.8M | 334.6M | 268.3M | 554.9M | 403.3M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 116.4M | 117.6M | 128.6M | 198.6M | 169.1M |
| Net Interest Income | (116.4M) | (117.6M) | (128.6M) | (198.6M) | (169.1M) |
| Other Non-Op Income/Expense | (63.2M) | (61.8M) | (93.5M) | (172.5M) | (142.7M) |
| Non-Operating Income (excl Interest) | (53.2M) | (55.8M) | (35.1M) | (26.1M) | (26.4M) |
| EBT (Pre-Tax Income) | 258.7M | 272.7M | 174.8M | 382.4M | 260.6M |
| Income Tax Expense | 55.1M | 58.2M | 44.8M | 82.6M | 62.6M |
| Bottom Line | |||||
| Net Income | 133.5M | 146.2M | 214.0M | 243.5M | 159.0M |
| Earnings from Cont. Ops | 203.6M | 214.5M | 130.0M | 299.7M | 198.0M |
| Earnings from Discont. Ops | — | — | 166.7M | — | — |
| Bottom Line Net Income | 132.7M | 146.2M | 211.7M | 234.7M | 153.4M |
| Per Share | |||||
| Basic EPS | $1.09 | $1.18 | $1.66 | $1.91 | $1.23 |
| Diluted EPS | $1.09 | $1.18 | $1.66 | $1.91 | $1.23 |
| Revenue Per Share | $44.70 | $44.15 | $40.15 | $54.13 | $50.82 |
| Shares | |||||
| Basic Shares Outstanding | 123.5M | 123.5M | 129.2M | 123.1M | 124.6M |
| Diluted Shares Outstanding | 123.5M | 123.5M | 124.6M | 123.1M | 124.6M |
| Profitability Metrics | |||||
| EBITDA | 518.2M | 530.6M | 507.3M | 789.7M | 635.5M |
| D&A | 143.2M | 140.3M | 203.9M | 208.7M | 205.8M |
| EBIT | 375.1M | 390.3M | 303.4M | 581.0M | 429.7M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026